Low plasma concentration of gefitinib in patients with EGFR exon 21 L858R point mutations shortens progression-free survival
Crossref DOI link: https://doi.org/10.1007/s00280-017-3285-x
Published Online: 2017-04-08
Published Print: 2017-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Okuda, Yuji
Sato, Kazuhiro
Sudo, Kazuhisa
Hasegawa, Yukiyasu
Asano, Mariko
Miura, Hajime
Takeda, Masahide
Sano, Masaaki
Watanabe, Hiroyuki
Kobayashi, Hiroyuki
Niioka, Takenori
Miura, Masatomo
Ito, Hiroshi
License valid from 2017-04-08